Major Trial Results Livestream: Anticoagulation in COVID-19

  • 8/4/21 11:42 AM
  • CCMB Communications & Public Affairs

The ACTIV4-a, ATTACC, & REMAP-CAP investigators will present the results of this multi-platform trial, in which critically ill adults were randomized to receive therapeutic anticoagulation with heparin or pharmacological thromboprophylaxis as per local usual care.

This live webcast includes a description on how the trial was done and what the role of therapeutic anticoagulation is in hospitalized patients with COVID-19, our results, an independent editorial and a panel discussion. The webcast can be accessed via the link below:

Date: Wednesday, August 4, 2021
Time:  15h30 Winnipeg (approximately 90 minutes)

Registration is free.